Cargando…
Baicalein inhibits the pharmacokinetics of simvastatin in rats via regulating the activity of CYP3A4
CONTEXT: Baicalein and simvastatin possess similar pharmacological activities and indications. The risk of their co-administration was unclear. OBJECTIVE: The interaction between baicalein and simvastatin was investigated to provide reference and guidance for the clinical application of the combinat...
Autores principales: | Meng, Meng, Li, Xin, Zhang, Xiuwen, Sun, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259816/ https://www.ncbi.nlm.nih.gov/pubmed/34214011 http://dx.doi.org/10.1080/13880209.2021.1942927 |
Ejemplares similares
-
Baicalein Inhibits Neuroapoptosis Via Pathways in Sevoflurane Induced Rats
por: Wang, Si, et al.
Publicado: (2018) -
Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats
por: Li, Ying, et al.
Publicado: (2019) -
Contribution of Baicalin on the Plasma Protein Binding Displacement and CYP3A Activity Inhibition to the Pharmacokinetic Changes of Nifedipine in Rats In Vivo and In Vitro
por: Cheng, Zhen-Yu, et al.
Publicado: (2014) -
Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2014) -
Regulation of bone formation by baicalein via the mTORC1 pathway
por: Li, Sheng-fa, et al.
Publicado: (2015)